PMC:7187150 / 548-982
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T14 | 36-43 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T15 | 258-265 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T16 | 297-302 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T17 | 317-322 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T9 | 145-153 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 269-277 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 346-354 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 357-366 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 28-29 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T26 | 49-52 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T27 | 66-72 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T28 | 289-302 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T29 | 317-322 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T30 | 370-371 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T31 | 428-433 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 36-43 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T2 | 88-90 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T3 | 258-265 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-303 | Sentence | denotes | To assess whether hrsACE2 — a decoy protein that has already been tested in phase I and II clinical trials — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. |
T6 | 304-434 | Sentence | denotes | Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagation of the virus. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
27 | 160-164 | Gene | denotes | ACE2 | Gene:59272 |
28 | 145-155 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
29 | 274-288 | Disease | denotes | CoV-2-infected | MESH:C000657245 |
30 | 346-366 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
31 | 294-296 | CellLine | denotes | E6 | CVCL:4582 |